These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 8071696

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pentavalent technetium-99m-DMSA uptake in a patient having multiple myeloma without amyloidosis.
    Ohnishi T, Noguchi S, Murakami N, Tajiri J, Morita M, Tamaru M, Hoshi H, Watanabe K.
    J Nucl Med; 1991 Sep; 32(9):1785-7. PubMed ID: 1652629
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Incidental visualization of hepatic hemangioma during Tc-99m (v) DMSA, Tl-201, and Tc-99m MDP imaging.
    Adalet I, Kocak M, Oguz H, Alagol F, Cantez S.
    Clin Nucl Med; 1995 Dec; 20(12):1106-7. PubMed ID: 8674308
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid.
    Clarke SE, Lazarus CR, Wraight P, Sampson C, Maisey MN.
    J Nucl Med; 1988 Jan; 29(1):33-8. PubMed ID: 2826723
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Analogy between tumor uptake of technetium(V)-99m dimercaptosuccinic acid (DMSA) and technetium-99m-MDP.
    Wulfrank DA, Schelstraete KH, Small F, Fallais CJ.
    Clin Nucl Med; 1989 Aug; 14(8):588-93. PubMed ID: 2553315
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Oxygen bubbling can improve the labelling of pentavalent technetium-99m dimercaptosuccinic acid.
    Kobayashi H, Suzuki KH, Sakahara H, Yao ZS, Yokoyama A, Konishi J.
    Eur J Nucl Med; 1995 Jun; 22(6):559-62. PubMed ID: 7556304
    [Abstract] [Full Text] [Related]

  • 13. Technetium-99m-pentavalent dimercaptosuccinic acid uptake in Hurthle cell tumor of the thyroid.
    Vergara E, Lastoria S, Varrella P, Lapenta L, Salvatore M.
    J Nucl Biol Med (1991); 1993 Jun; 37(2):65-8. PubMed ID: 8396979
    [Abstract] [Full Text] [Related]

  • 14. Bone metastases demonstrated by pentavalent Tc-99m DMSA and Tc-99m HMDP.
    Hirano T, Otake H.
    Clin Nucl Med; 1997 Sep; 22(9):640-1. PubMed ID: 9298304
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Scintigraphic evaluation of tenosynovial giant-cell tumor using technetium-99m(V)-dimercaptosuccinic acid.
    Kobayashi H, Sakahara H, Hosono M, Shirato M, Konishi J, Kotoura Y, Yamamuro T, Endo K.
    J Nucl Med; 1993 Oct; 34(10):1745-7. PubMed ID: 8410292
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
    Bevan JA, Tofe AJ, Benedict JJ, Francis MD, Barnett BL.
    J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.